Somnomed Ltd (SOM) - Net Assets

Latest as of December 2025: AU$50.04 Million AUD ≈ $35.40 Million USD

Based on the latest financial reports, Somnomed Ltd (SOM) has net assets worth AU$50.04 Million AUD (≈ $35.40 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$79.90 Million ≈ $56.53 Million USD) and total liabilities (AU$29.86 Million ≈ $21.13 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Somnomed Ltd (SOM) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	AU$50.04 Million
% of Total Assets	62.62%
Annual Growth Rate	31.35%
5-Year Change	44.26%
10-Year Change	41.92%
Growth Volatility	67.76

Somnomed Ltd - Net Assets Trend (2003–2025)

This chart illustrates how Somnomed Ltd's net assets have evolved over time, based on quarterly financial data. Also explore Somnomed Ltd assets under control for the complete picture of this company's asset base.

Annual Net Assets for Somnomed Ltd (2003–2025)

The table below shows the annual net assets of Somnomed Ltd from 2003 to 2025. For live valuation and market cap data, see Somnomed Ltd market cap and net worth.

Year	Net Assets	Change
2025-06-30	AU$46.39 Million ≈ $32.82 Million	+3.03%
2024-06-30	AU$45.02 Million ≈ $31.86 Million	+100.97%
2023-06-30	AU$22.40 Million ≈ $15.85 Million	-19.38%
2022-06-30	AU$27.79 Million ≈ $19.66 Million	-13.59%
2021-06-30	AU$32.16 Million ≈ $22.75 Million	-4.96%
2020-06-30	AU$33.84 Million ≈ $23.94 Million	+89.87%
2019-06-30	AU$17.82 Million ≈ $12.61 Million	-45.62%
2018-06-30	AU$32.77 Million ≈ $23.19 Million	+5.86%
2017-06-30	AU$30.95 Million ≈ $21.90 Million	-5.30%
2016-06-30	AU$32.69 Million ≈ $23.13 Million	+51.98%
2015-06-30	AU$21.51 Million ≈ $15.22 Million	+71.11%
2014-06-30	AU$12.57 Million ≈ $8.89 Million	+8.61%
2013-06-30	AU$11.57 Million ≈ $8.19 Million	+29.74%
2012-06-30	AU$8.92 Million ≈ $6.31 Million	+43.47%
2011-06-30	AU$6.22 Million ≈ $4.40 Million	+10.02%
2010-06-30	AU$5.65 Million ≈ $4.00 Million	+30.40%
2009-06-30	AU$4.33 Million ≈ $3.07 Million	-27.88%
2008-06-30	AU$6.01 Million ≈ $4.25 Million	+53.55%
2007-06-30	AU$3.91 Million ≈ $2.77 Million	+20.99%
2006-06-30	AU$3.23 Million ≈ $2.29 Million	-55.09%
2005-06-30	AU$7.20 Million ≈ $5.10 Million	+4598.70%
2004-06-30	AU$-160.08K ≈ $-113.26K	-239.20%
2003-06-30	AU$115.00K ≈ $81.37K	--

Equity Component Analysis

This analysis shows how different components contribute to Somnomed Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 7793664300.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (June 2025)

Component	Amount	Percentage
Common Stock	AU$119.96 Million	258.59%
Other Comprehensive Income	AU$4.37 Million	9.41%
Total Equity	AU$46.39 Million	100.00%

Somnomed Ltd Competitors by Market Cap

The table below lists competitors of Somnomed Ltd ranked by their market capitalization.

Company	Market Cap
Rand Mining Ltd AU:RND	$94.57 Million
Avgol Industries 1953 Ltd TA:AVGL	$94.63 Million
TVS Electronics Limited NSE:TVSELECT	$94.65 Million
Economic Investment Trust Ltd TO:EVT	$94.65 Million
eXoZymes, Inc. NASDAQ:EXOZ	$94.53 Million
Martin Midstream Partners LP NASDAQ:MMLP	$94.51 Million
Papoutsanis S.A AT:PAP	$94.50 Million
Oneview Healthcare Plc AU:ONE	$94.46 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Somnomed Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 45,024,195 to 46,390,473, a change of 1,366,278 (3.0%).
Net loss of 3,456,329 reduced equity.
Other comprehensive income decreased equity by 4,965,130.
Other factors increased equity by 9,787,737.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	AU$-3.46 Million	-7.45%
Other Comprehensive Income	AU$-4.97 Million	-10.7%
Other Changes	AU$9.79 Million	+21.1%
Total Change	AU$-	3.03%

Book Value vs Market Value Analysis

This analysis compares Somnomed Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 2.79x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2004-06-30	AU$-0.05	AU$0.61	x
2005-06-30	AU$0.56	AU$0.61	x
2006-06-30	AU$0.24	AU$0.61	x
2007-06-30	AU$0.19	AU$0.61	x
2008-06-30	AU$0.16	AU$0.61	x
2009-06-30	AU$0.10	AU$0.61	x
2010-06-30	AU$0.12	AU$0.61	x
2011-06-30	AU$0.13	AU$0.61	x
2012-06-30	AU$0.17	AU$0.61	x
2013-06-30	AU$0.27	AU$0.61	x
2014-06-30	AU$0.28	AU$0.61	x
2015-06-30	AU$0.43	AU$0.61	x
2016-06-30	AU$0.63	AU$0.61	x
2017-06-30	AU$0.60	AU$0.61	x
2018-06-30	AU$0.65	AU$0.61	x
2019-06-30	AU$0.25	AU$0.61	x
2020-06-30	AU$0.51	AU$0.61	x
2021-06-30	AU$0.39	AU$0.61	x
2022-06-30	AU$0.34	AU$0.61	x
2023-06-30	AU$0.27	AU$0.61	x
2024-06-30	AU$0.37	AU$0.61	x
2025-06-30	AU$0.22	AU$0.61	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Somnomed Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -7.45%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -3.10%
• Asset Turnover: 1.38x
• Equity Multiplier: 1.75x
Recent ROE (-7.45%) is above the historical average (-18.17%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2004	0.00%	-1978.89%	0.05x	0.00x	AU$-540.99K
2005	-45.36%	-866.20%	0.05x	1.10x	AU$-3.99 Million
2006	-129.49%	-234.52%	0.44x	1.26x	AU$-4.51 Million
2007	-83.68%	-144.03%	0.48x	1.20x	AU$-3.67 Million
2008	-45.45%	-74.66%	0.52x	1.17x	AU$-3.33 Million
2009	-41.97%	-22.75%	1.32x	1.39x	AU$-2.25 Million
2010	13.91%	7.15%	1.40x	1.39x	AU$221.08K
2011	11.90%	5.91%	1.43x	1.40x	AU$117.83K
2012	6.22%	3.42%	1.25x	1.46x	AU$-319.04K
2013	5.16%	3.18%	1.01x	1.61x	AU$-551.39K
2014	3.29%	1.34%	1.58x	1.55x	AU$-827.96K
2015	2.80%	1.73%	1.24x	1.30x	AU$-1.54 Million
2016	0.50%	0.37%	1.09x	1.22x	AU$-3.15 Million
2017	-10.38%	-6.78%	1.20x	1.28x	AU$-6.57 Million
2018	6.41%	4.42%	1.15x	1.27x	AU$-1.30 Million
2019	-0.22%	-0.07%	1.69x	1.95x	AU$-1.82 Million
2020	-3.31%	-1.95%	0.93x	1.82x	AU$-4.50 Million
2021	-3.71%	-1.90%	1.12x	1.75x	AU$-4.41 Million
2022	-15.97%	-6.11%	1.25x	2.09x	AU$-7.22 Million
2023	-35.70%	-9.57%	1.34x	2.79x	AU$-10.24 Million
2024	-27.19%	-13.36%	1.31x	1.55x	AU$-16.74 Million
2025	-7.45%	-3.10%	1.38x	1.75x	AU$-8.10 Million

Industry Comparison

This section compares Somnomed Ltd's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

Industry: Medical Devices
Average net assets among peers: $154,202,641
Average return on equity (ROE) among peers: -53.15%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Somnomed Ltd (SOM)	AU$50.04 Million	0.00%	0.60x	$94.56 Million
4DMEDICAL Ltd (4DX)	$3.78 Million	-104.20%	0.44x	$1.66 Billion
Adherium Ltd (ADR)	$34.53 Million	-3.63%	0.08x	$7.37 Million
Aroa Biosurgery Ltd (ARX)	$9.77 Million	0.00%	0.24x	$157.04 Million
Atomo Diagnostics Ltd (AT1)	$14.79 Million	-67.33%	0.11x	$13.76 Million
Avita Medical Inc (AVH)	$5.12 Million	-224.74%	0.50x	$127.84 Million
Anteris Technologies Global Corp (AVR)	$38.56 Million	-65.49%	0.07x	$572.20 Million
Control Bionics Ltd (CBL)	$5.51 Million	-110.89%	0.49x	$16.32 Million
Cardiex Ltd (CDX)	$4.88 Million	56.04%	0.31x	$13.23 Million
Compumedics Ltd (CMP)	$23.59 Million	5.75%	0.77x	$40.28 Million
Cochlear Ltd (COH)	$1.40 Billion	-17.00%	0.84x	$4.64 Billion

About Somnomed Ltd

AU:SOM Australia Medical Devices

Market Cap

$94.56 Million

AU$133.64 Million AUD

Market Cap Rank

#19400 Global

#641 in Australia

Share Price

AU$0.61

Change (1 day)

+7.02%

52-Week Range

AU$0.48 - AU$0.89

All Time High

AU$3.28